Cobas® core CA 19-9 II EIA: New CA 19-9 enzyme immunoassay with high correlation to radioimmunoassays

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 2911-2914

  Birk, B ^a   Henne, V ^a   Hipp, B ^a   Meyer, A ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Automation; CA 19 9; Correlation to RIA's; Enzyme immunoassay

Indexed keywords

CA 19-9 ANTIGEN; HETEROPHILE ANTIBODY; MUCIN;

ACCURACY; ANALYTIC METHOD; BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GASTROINTESTINAL TUMOR; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; RADIOIMMUNOASSAY; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD;

CA-19-9 ANTIGEN; HUMANS; IMMUNOENZYME TECHNIQUES; RADIOIMMUNOASSAY; REAGENT KITS, DIAGNOSTIC;

EID: 0030610823     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Koprowski H, Herlyn M, Steplewski Z, Sears HF: Specific antigen in serum of patients with colon carcinoma. Science 212: 53-55, 1981.
2. Koprowski H, Steplewski Z, Mitschell K, Herlyn M, Herlyn D, Fuhrer P: Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 5: 957-971, 1979.
3. Del Villano BC, Brenman S, Brock P, Bucher C, Liu V, Mc Clure M, Rake B, Space S, Westrick B, Schoenmaker H, Zurawski VR: Radioimmunometric assay for a monoclonal antibody defined tumour marker CA 19-9. Clin Chem 29: 549-552, 1983.
4. Mäkelä O, Jalanko H: Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer 53: 197-202, 1986.
5. Yokoyama Y, Akagi M: Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system. Gut 28: 323-329, 1987.
6. Favero G, Venturini R, Panucci A, Naccarato R: CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis. Eur J Cancer 21: 429-432, 1985.
7. Bützow GW, Jessen K, Klapdor R, Soehendra N, Wargenan M, Classen M, Greten H, Thiele HG: Multiparametric Tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic disorders. Hepato-Gastroenterol 32: 141-145, 1985.
8. Buchterkirche W, Baum U, Brandt B, van Dalen A, Förster R, Hubl W, Kapp S, Klapdor R, Spitz J, Wieser N, Klapdor: Current Tumor Diagnosis, 7th Symposium on Tumour Markers, 481-486, Hamburg 1993.